Outlook Therapeutics
OTLK
Outlook Therapeutics (OTLK) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $4.00 | Aug 14, 2026 |
| BTIG | Upgraded | Neutral → Buy | $4.00 | Jul 27, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $1.60 from $0.50 | Jul 27, 2026 |
| Ascendiant Capital | Maintained | Buy | $10.00 from $6.00 | Jun 11, 2026 |
| BTIG | Downgraded | Buy → Neutral | — | May 18, 2026 |
| Ascendiant Capital | Maintained | Buy | $6.00 from $10.00 | Mar 11, 2026 |
| Chardan Capital | Maintained | Neutral | $1.00 | Feb 18, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $0.50 | Feb 18, 2026 |
| Chardan Capital | Maintained | Neutral | $1.00 from $3.00 | Jan 5, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $0.50 from $1.00 | Jan 2, 2026 |
| Ascendiant Capital | Maintained | Buy | $10.00 from $8.00 | Dec 22, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $1.00 | Sep 30, 2025 |
| Ascendiant Capital | Maintained | Buy | $8.00 from $21.00 | Sep 22, 2025 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $1.00 | Aug 29, 2025 |
| Guggenheim | Downgraded | Buy → Neutral | — | Aug 29, 2025 |
| Chardan Capital | Maintained | Neutral | $3.00 | Aug 28, 2025 |
| Chardan Capital | Maintained | Neutral | $3.00 | Aug 15, 2025 |
| Ascendiant Capital | Maintained | Buy | $21.00 from $24.00 | Jun 6, 2025 |
| Ascendiant Capital | Maintained | Buy | $24.00 from $33.00 | Feb 24, 2025 |
| Chardan Capital | Maintained | Neutral | $3.00 | Feb 18, 2025 |
Frequently asked questions
What is the latest analyst rating on OTLK?
On Aug 14, 2026, BTIG maintained Outlook Therapeutics at Buy with a price target of $4.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.